You Angie's Form 4 filing
Oric Pharmaceuticals, Inc. (ORIC) · filed Jun 23, 2025
- Accession no.
- 0001415889-25-018014
- Filed
- Jun 23, 2025
- Trade date
- Jun 20-23, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $263.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| You AngieCIK 0001647664 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Common Stock | PPurchaseAcquired | +26,597 | $9.39F1 | +$249,745.83 | 26,597 | Direct | |
| Jun 23, 2025 | Common Stock | PPurchaseAcquired | +1,403 | $9.43 | +$13,230.29 | 28,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average share price of an aggregate total of 26,597 shares purchased in the price range of $9.14 to $9.50 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.